期刊文献+

登革热患者血清IL-17A和IL-22水平与疾病的相关性分析 被引量:2

下载PDF
导出
摘要 目的探讨登革热患者血清白细胞介素(IL)-17A、IL-22水平变化规律,分析其与登革热的关系,并探讨其意义。方法采用酶联免疫吸附(ELISA)法分别检测登革热组患者和对照组健康人血清IL-17A、IL-22水平,采用全自动血细胞分析仪检测2组白细胞计数(WBC)和血小板计数(PLT),并分析IL-17A、IL-22和WBC、PLT之间的相关性,通过ROC曲线分析IL-17A、IL-22的诊断截断点及其对登革热的诊断价值。结果登革热组IL-17A和IL-22水平均显著高于对照组,差异具有统计学意义(P<0.05),且两者之间呈正相关(P=0.000);同时IL-17A、IL-22分别与WBC、PLT呈负相关(P<0.05)。ROC曲线分析发现,血清IL-17A、IL-22最优截断点分别为1.54、3.41pg/mL,灵敏度分别为95.52%、92.54%,特异度分别为70.00%、100.00%,曲线下面积分别为0.851、0.913。结论在登革热患者中,血清IL-17A与IL-22表达上调,且与疾病的活动度呈正相关,两者的检测有助于登革热的诊断。
出处 《国际检验医学杂志》 CAS 2018年第16期2050-2052,共3页 International Journal of Laboratory Medicine
基金 国家自然科学基金青年基金资助项目(81503317) 广东省科技计划资助项目(2014A020212502) 广东省中医院院内专项(YN2015QN06)
  • 相关文献

参考文献4

二级参考文献93

  • 1Park H, Li I, Yang Xo, et al. A distinct lineage of CIM T cells reg- ulates tissue inflammation by producing interleukin 17 [ J. Nat Im- munol, 2005,6 ( 11 ) : 1133-1141.
  • 2Ge J, Wang K, Meng QH, et al. Implication of Thl7 and Thl cells in patients with chronic active hepatitis B [ J ]. J Clin Immunol, 2010,30( 1 ) :60-67.
  • 3Harrington LE, Hatton RD, Mangan ducing CD4+ effector T cells develop The helper typel and 2 lineage [ J ]. 1123-1132 PR, et al. Interleukin 17 pro- via a lineage distinct from the Nat Immunol, 2005,6 ( 11 ) .
  • 4Bettelli E, Oukka M, Kuchroo VK. Thl7 cells in the circle of im- munity and autoimmunity [ J ]. Nat Immunol, 2007,8 (4) :345-350.
  • 5Zheng Y, Danilenko DM, Valdez P, et al. lnterleukin-22,a T(H) 17 cytokine,mediates IL-23-induced dermal inflammation and acan- thosis [ J ]. Nature, 2007,445 ( 7128 ) : 648 -651.
  • 6Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Interleukin- 22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation [ J ]. hnmunity, 2007,27 ( 4 ) : 647-659.
  • 7WHO Technical Advisory Committee (TAC) on DHF for SE A- sia and Western Pacific Regions. Guides for diagnosis, treat- ment, surveillance, prevention and control of dengue hemor- rhagic fever[R]. Geneva: World Health Organization, 1975.
  • 8BANDYOPADHYAY S, LUM L C, KROEGER A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever[J]. Tropical Medi- cine and International Health, 2006, 11(8): 1238-1255.
  • 9World Health Organization. Dengue-guidelines for diagnosis, treatment, prevention and control[R]. Geneva: World Health Or- ganization, 2009.
  • 10KALAYANAROOJ S. Dengue classification: current WHO vs. the newly suggested classification for better clinical applica- tion[J]. Journal of the Medical Association of Thailand, 2011, 94 (Suppl. 3): S74-S84.

共引文献58

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部